The Effects of RVX000222 on Glucose Metabolism in Individuals With Pre-diabetes

NCT01728467 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes

Interventions

DRUG: RVX000222
DRUG: Placebo, RVX000222

Sponsor

Resverlogix Corp

Collaborators

[object Object]
[object Object]